Cite
Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates
MLA
Xiao, Jia-ling, et al. “Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates.” Infection and Drug Resistance, 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284028871&authtype=sso&custid=ns315887.
APA
Xiao, J., Xu, G., Hoog, S. de, Qiao, J., Fang, H., & Li, Y. (2020). Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates. Infection and Drug Resistance.
Chicago
Xiao, Jia-ling, Guo-chao Xu, S. de Hoog, Jian-jun Qiao, Hong Fang, and Ya-li Li. 2020. “Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates.” Infection and Drug Resistance. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284028871&authtype=sso&custid=ns315887.